Togo becomes the latest West African country to eliminate trachoma, an eye disease that can cause permanent blindness, as a public health problem. 

It’s the fourth country on the continent to be validated by World health Organization (WHO) as having reached the elimination milestone after Morocco in 2016, Ghana in 2018 and The Gambia in 2021. 

Trachoma is caused by bacteria and mainly affects children and women. Repeated infection can severely scar the inside of the eyelid, turning it inwards and causing the eyelashes to rub against the eyeball. This results in constant pain and light intolerance. Left untreated it leads to visual impairment or blindness.

“Togo’s achievement is a significant step in the progress towards trachoma elimination. Children across the country and their families can now live without the fear of the severe impacts of this preventable disease thanks to sustained control measures,” said Dr Matshidiso Moeti, WHO Regional Director for Africa.

Efforts to eliminate trachoma in Togo started in 1989, with its inclusion as one of the priority neglected tropical diseases under the national control programme. 

The major elimination strategy was screening and treatment of people with late trachoma complications. 

Community participation was central to the success in Togo, with community health workers trained to identify suspected cases and refer them for examination and treatment.

Togo also led series of awareness campaigns focusing on the importance of facial cleanliness and personal hygiene in the fight against trachoma and invested in significant improvements in the provision of safe water and access to better sanitation.

Validation of trachoma elimination as a public health problem in Togo was based on evidence. 

Several population-based trachoma surveys were conducted starting from 2006 to 2017. 

The 2017 survey using WHO recommended methodology found that the prevalence of key indicators was below the WHO trachoma elimination threshold. 

There was also evidence that Togo’s health system is able to identify and treat new cases of late complications of trachoma.